Quadrant Biosciences Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Employees
  • 92

Employees

  • Latest Deal Type
  • Later Stage VC
  • (Cancelled)

  • Latest Deal Amount
  • $25.4M

  • Investors
  • 5

Quadrant Biosciences General Information

Description

Operator of a life science company intended to offer molecular diagnostic tools for health issues. The company's collaborative research relationships with a number of institutions to explore and discover novel biomarker technologies, enabling healthcare professionals to get help with autism spectrum disorder, concussion, and Parkinson's disease by leveraging its expertise in RNA analysis to address the COVID-19 pandemic.

Contact Information

Formerly Known As
Motion Intelligence
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Diagnostic Equipment
Corporate Office
  • 505 Irving Avenue
  • Suite 3100 AB
  • Syracuse, NY 13210
  • United States
+1 (607) 000-0000

Quadrant Biosciences Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Quadrant Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
14. Later Stage VC 02-Nov-2023 $25.4M Cancelled Generating Revenue
13. Later Stage VC 08-Aug-2023 00.00 000.00 Completed Generating Revenue
12. Grant 15-Sep-2020 00.000 000.00 Completed Generating Revenue
11. Equity Crowdfunding 15-Aug-2020 00.000 000.00 Completed Generating Revenue
10. Later Stage VC 23-Jan-2020 00.00 000.00 Completed Generating Revenue
9. Later Stage VC 01-Jan-2020 0000 000.00 Completed Generating Revenue
8. Later Stage VC 27-Jun-2019 00000 00.000 Completed Generating Revenue
7. Grant 19-Jun-2019 00000 00.000 Completed Generating Revenue
6. Grant 19-Sep-2018 $2.25M $5.68M Completed Generating Revenue
5. Debt - General 01-Mar-2018 $5.68M Completed Generating Revenue
To view Quadrant Biosciences’s complete valuation and funding history, request access »

Quadrant Biosciences Patents

Quadrant Biosciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3847281-A1 Methods and machine learning for disease diagnosis Pending 25-Oct-2018 00000000
US-20210383924-A1 Methods and machine learning for disease diagnosis Pending 25-Oct-2018 00000000
CA-3117218-A1 Methods and machine learning for disease diagnosis Pending 25-Oct-2018 00000000
JP-2022512829-A Methods and machine learning for disease diagnosis Pending 25-Oct-2018 00000000
EP-3847281-A4 Methods and machine learning for disease diagnosis Pending 25-Oct-2018 G16H50/20 0
To view Quadrant Biosciences’s complete patent history, request access »

Quadrant Biosciences Executive Team (16)

Name Title Board Seat Contact Info
Benjamin Perry Co-Chief Executive Officer & President
Richard Uhlig Founder, Co-Chief Executive Officer & Chairman
Bryan Greene Chief Executive Officer, Quadrant Laboratories
Richard Bongo Chief Financial Officer & Board Member
Arthur Schoen Chief Operating Officer
You’re viewing 5 of 16 executive team members. Get the full list »

Quadrant Biosciences Board Members (8)

Name Representing Role Since
Andrew Rock Self Board Member 000 0000
Ira Fedder MD Quadrant Biosciences Executive Vice President of Strategy & Board Member 000 0000
James Croke JD Quadrant Biosciences General Counsel & Board Member 000 0000
Mary Tyszko Self Board Member 000 0000
Peter Cohen Self Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »

Quadrant Biosciences Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Quadrant Biosciences Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Institutes of Health Government Minority 000 0000 000000 0
ICBM Venture Capital Venture Capital Minority 000 0000 000000 0
Pearl Gray Equity Partners Impact Investing Minority 000 0000 000000 0
National Institute of Mental Health Government 000 0000 000000 0
CenterState CEO Government 000 0000 000000 0
To view Quadrant Biosciences’s complete investors history, request access »

Quadrant Biosciences Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Frazier Behavioral Health 01-Mar-2022 0000000000 Clinics/Outpatient Services
To view Quadrant Biosciences’s complete acquisitions history, request access »

Quadrant Biosciences Subsidiaries (1)

Company Name Industry Location Founded
Frazier Behavioral Health Clinics/Outpatient Services Pepper Pike, OH 0000
To view Quadrant Biosciences’s complete subsidiaries history, request access »

Quadrant Biosciences FAQs

  • When was Quadrant Biosciences founded?

    Quadrant Biosciences was founded in 2012.

  • Who is the founder of Quadrant Biosciences?

    Richard Uhlig is the founder of Quadrant Biosciences.

  • Who is the CEO of Quadrant Biosciences?

    Benjamin Perry, Richard Uhlig, and Bryan Greene are the CEOs of Quadrant Biosciences.

  • Where is Quadrant Biosciences headquartered?

    Quadrant Biosciences is headquartered in Syracuse, NY.

  • What is the size of Quadrant Biosciences?

    Quadrant Biosciences has 92 total employees.

  • What industry is Quadrant Biosciences in?

    Quadrant Biosciences’s primary industry is Biotechnology.

  • Is Quadrant Biosciences a private or public company?

    Quadrant Biosciences is a Private company.

  • What is Quadrant Biosciences’s current revenue?

    The current revenue for Quadrant Biosciences is 000000.

  • How much funding has Quadrant Biosciences raised over time?

    Quadrant Biosciences has raised $41.8M.

  • Who are Quadrant Biosciences’s investors?

    National Institutes of Health, ICBM Venture Capital, Pearl Gray Equity Partners, National Institute of Mental Health, and CenterState CEO have invested in Quadrant Biosciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »